Clinical Trial Update: Empagliflozin Adjunctive Therapy in Bipolar Depression [NA]

View source ↗

Summary

Clinical trial update on empagliflozin as adjunctive therapy for bipolar depression, sponsored by the University of Sao Paulo; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Bipolar Disorder
• Insulin Resistance

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Bipolar Disorder, Bipolar Depression | NA | Status: NOT_YET_RECRUITING